Phase 1-2 of Azacitidine + Lenalidomide for Previously Untreated Elderly Patients With Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Azacitidine
Related studies linked through entity extraction aliases.
Controlled Study of Post-transplant Azacitidine for Prevention of Acute Myelogenous Leukemia and Myelodysplastic Syndrome Relapse (VZ-AML-PI-0129)
- Status
- COMPLETED
- Phase
- PHASE3
Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)
- Status
- COMPLETED
- Phase
- PHASE2
Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine
- Status
- COMPLETED
- Phase
- PHASE1
Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction Therapy
- Status
- UNKNOWN
- Phase
- PHASE2
Phase 2 Study of Azacitidine (Vidaza) vs MGCD0103 vs Combination in Elderly Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
- Status
- TERMINATED
- Phase
- PHASE2
Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide
- Status
- COMPLETED
- Phase
- PHASE1
Ph II Study of Azacitidine in Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Study of 5-Azacytidine With Ara-C in Patients With Relapsed/Refractory Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Azacytidine and Valproic Acid in Patients With Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome
- Status
- TERMINATED
- Phase
- PHASE2
AVIDA The Vidaza® (Azacitidine) Patient Registry
- Status
- COMPLETED
- Phase
- N/A
Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Phase II Study of Maintenance With Azacitidine in MDS Patients
- Status
- TERMINATED
- Phase
- PHASE2